XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (11,433) $ (16,963)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 2,562 2,586
Accrued interest on marketable securities, net (294) (398)
Stock-based compensation expense 13,552 11,440
Amortization of debt issuance costs 32 45
Gain on financial instruments (112) (210)
Deferred taxes 25 47
Changes in operating assets and liabilities:    
Accounts receivable (218) (2,183)
Prepaid expenses and other current assets (1,633) (2,654)
Accounts payable and accrued liabilities (3,873) (1,290)
Deferred costs (1,311) (859)
Deferred revenues 3,654 824
Net cash provided by (used in) operating activities 951 (9,615)
Cash flows from investing activities:    
Purchase of marketable securities (7,149) (20,987)
Proceeds from sales, maturities and redemptions of marketable securities 15,626 38,122
Purchases of property and equipment (306) (229)
Capitalized software development costs [1] (1,363) (1,141)
Net cash provided by investing activities 6,808 15,765
Cash flows from financing activities:    
Payments for taxes related to net settlement of equity awards (5,678) (1,984)
Proceeds from stock option exercises 1,171 1,416
Net cash used in financing activities (4,507) (568)
Net increase in cash and cash equivalents and restricted cash 3,252 5,582
Cash and cash equivalents and restricted cash, beginning of period 40,927 112,337
Cash and cash equivalents and restricted cash, end of period $ 44,179 $ 117,919
[1] See Note 3 for additional information regarding non-cash investing activities for the three months ended March 31, 2024 and 2023 related to capitalized software development costs.